Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Siebert

Showing results (101-110 of 359) with videos related to

Pageof 36
Sort By:
Journal of Hepatology|August 7, 2008
Market uptake of new antiviral drugs for the treatment of hepatitis CBeate Lettmeier, Nikolai Mühlberger, Ruth Schwarzer, et al.
Cost Effectiveness and Resource Allocation : C/E|October 24, 2019
Cost-comparison analysis of a multiplatform tumour profiling service to guide advanced cancer treatmentGilbert Spizzo, Uwe Siebert, Guenther Gastl, et al.
Scientific Reports|August 1, 2020
Quality of life analysis after stereotactic radiofrequency ablation of liver tumorsPeter Schullian, Anja Gertl, Gregor Laimer, et al.
BMC Gastroenterology|May 7, 2020
Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKORSabine Hoffmann, Alexander Crispin, Doris Lindoerfer, et al.
German Medical Science : GMS E-Journal|September 26, 2022
Additional treatment with mistletoe extracts for patients with breast cancer compared to conventional cancer therapy alone - efficacy and safety, costs and cost-effectiveness, patients and social aspects, and ethical assessmentPetra Schnell-Inderst, Caroline Steigenberger, Marcel Mertz, et al.
Journal of Comparative Effectiveness Research|November 2, 2017
Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1Beate Jahn, Marjan Arvandi, Ursula Rochau, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 24, 2022
Cost-effectiveness of testing for CYP2C19 loss-of-function carriers following transient ischemic attack/minor stroke: A Canadian perspectiveAndrew Micieli, Nishita Singh, Beate Jahn, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 18, 2018
Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assaysVladica M Veličković, Ursula Rochau, Annette Conrads-Frank, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 20, 2025
Patient-Reported Outcome Measures in Patients with Diabetes Mellitus: Findings from the Diabetes Landeck CohortVeronika Haslwanter, Lára R Hallson, Ursula Rochau, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 3, 2024
Valuation of the EQ-5D-3L in JordanAbeer Al Rabayah, Bram Roudijk, Fredrick Dermawan Purba, et al.
Pageof 36

Showing results (101-110 of 359) with videos related to

Sort By:
Pageof 36
Journal of Hepatology|August 7, 2008
Market uptake of new antiviral drugs for the treatment of hepatitis CBeate Lettmeier, Nikolai Mühlberger, Ruth Schwarzer, et al.
Cost Effectiveness and Resource Allocation : C/E|October 24, 2019
Cost-comparison analysis of a multiplatform tumour profiling service to guide advanced cancer treatmentGilbert Spizzo, Uwe Siebert, Guenther Gastl, et al.
Scientific Reports|August 1, 2020
Quality of life analysis after stereotactic radiofrequency ablation of liver tumorsPeter Schullian, Anja Gertl, Gregor Laimer, et al.
BMC Gastroenterology|May 7, 2020
Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKORSabine Hoffmann, Alexander Crispin, Doris Lindoerfer, et al.
German Medical Science : GMS E-Journal|September 26, 2022
Additional treatment with mistletoe extracts for patients with breast cancer compared to conventional cancer therapy alone - efficacy and safety, costs and cost-effectiveness, patients and social aspects, and ethical assessmentPetra Schnell-Inderst, Caroline Steigenberger, Marcel Mertz, et al.
Journal of Comparative Effectiveness Research|November 2, 2017
Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1Beate Jahn, Marjan Arvandi, Ursula Rochau, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 24, 2022
Cost-effectiveness of testing for CYP2C19 loss-of-function carriers following transient ischemic attack/minor stroke: A Canadian perspectiveAndrew Micieli, Nishita Singh, Beate Jahn, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 18, 2018
Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assaysVladica M Veličković, Ursula Rochau, Annette Conrads-Frank, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 20, 2025
Patient-Reported Outcome Measures in Patients with Diabetes Mellitus: Findings from the Diabetes Landeck CohortVeronika Haslwanter, Lára R Hallson, Ursula Rochau, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 3, 2024
Valuation of the EQ-5D-3L in JordanAbeer Al Rabayah, Bram Roudijk, Fredrick Dermawan Purba, et al.
Pageof 36